Therefore, CD4+CD25+ Treg may have a major role in regulating the expansion of CD8+ T cell subsets during repopulation of the lymphopenic environment after AHSCT in AD patients (55, 64). The gene discussed is CD8A; the disease is Alzheimer disease.